Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
MCL1 is essential for the survival of stem and progenitor cells of multiple lineages, and is unique among pro-survival BCL2 family members in that it is rapidly turned over through the action of ubiquitin ligases. B- and mantle-cell lymphomas, chronic myeloid leukaemia, and multiple myeloma, however, express abnormally high levels of MCL1, contributing to chemoresistance and disease relapse. The mechanism of MCL1 overexpression in cancer is not well understood. Here we show that the deubiquitinase USP9X stabilizes MCL1 and thereby promotes cell survival. USP9X binds MCL1 and removes the Lys 48-linked polyubiquitin chains that normally mark MCL1 for proteasomal degradation. Increased USP9X expression correlates with increased MCL1 protein in human follicular lymphomas and diffuse large B-cell lymphomas. Moreover, patients with multiple myeloma overexpressing USP9X have a poor prognosis. Knockdown of USP9X increases MCL1 polyubiquitination, which enhances MCL1 turnover and cell killing by the BH3 mimetic ABT-737. These results identify USP9X as a prognostic and therapeutic target, and they show that deubiquitinases may stabilize labile oncoproteins in human malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Phosphorylation of MCL1 at S159 and T163 also affects the USP9X-MCL1 interaction [121].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [121]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.027 · Cited by 1,240
Self-citationThe molecular classification of multiple myeloma
Zhan, F., Huang, Y., Colla, S., Stewart, J. P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., et al. (2006) · Blood · doi:10.1182/blood-2005-11-013458 · Cited by 1,133
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T. F. E., Bernd, H.-W., Cogliatti, S. B., Dierlamm, J., Feller, A. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055351 · Cited by 1,006
Maurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881
Zhong, Q., Gao, W., Du, F., & Wang, X. (2005) · Cell · doi:10.1016/j.cell.2005.06.009 · Cited by 842
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
Opferman, J. T., Letai, A., Beard, C., Sorcinelli, M. D., Ong, C. C., & Korsmeyer, S. J. (2003) · Nature · doi:10.1038/nature02067 · Cited by 801
Cited by
Items 501–600 of 630
Aksoy, O., Lind, J., Sunder-Plassmann, V., Vallet, S., & Podar, K. (2022) · Cytokine · doi:10.1016/j.cyto.2022.156062 · Cited by 13
Li, B., Liu, J., Chen, J., Wang, Z., Mao, Y., & Chen, Y. (2015) · PubMed Central · Cited by 7
Self-citationPerturbed Signaling and Role of Posttranslational Modifications in Cancer Drug Resistance
Aggarwal, S., Kandpal, M., Asthana, S., & Yadav, A. K. (2017) · Springer eBooks · doi:10.1007/978-3-319-48683-3_22 · Cited by 8
Unraveling the Mechanism of Action of Ubiquitin-Specific Protease 5 and Its Inhibitors in Tumors
Wang, J., Fang, S., Jiang, Y., & Hua, Q. (2024) · Clinical Medicine Insights Oncology · doi:10.1177/11795549241281932 · Cited by 13
Kastnes, M. H., Aass, K. R., Bouma, S. A., Årseth, C., Zahoor, M., Yurchenko, M., & Standal, T. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1197542 · Cited by 6
Séry, Q., Rabé, M., Oliver, L., Vallette, F. M., & Gratas, C. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.162 · Cited by 8
Bui, I., Baritaki, S., Libra, M., Zaravinos, A., & Bonavida, B. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0250 · Cited by 6
Oncoapoptotic Markers in Oral Cancer: Prognostics and Therapeutic Perspective
Jain, A., Bundela, S., Tiwari, R. P., & Bisen, P. S. (2014) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-014-0104-5 · Cited by 7
Global analysis of cancer cell responses to USP9X inhibition
Schenk, P., Devine, S. M., Cobbold, S. A., Geoghegan, N. D., Kyran, E. L., Ang, C., Alexandrovics, J. A., Calleja, D. J., Multari, D. H., Vaibhav, V., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00742-y · Cited by 4
Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer development
Koo, H., Park, K. C., Sohn, H. A., Kang, M., Kim, D. J., Park, Z., Park, S., Min, S. H., Park, S., You, Y.-M., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-54476-8 · Cited by 7
Murali, P., Kavitha, B., & Narasimhan, M. (2024) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_517_24 · Cited by 8
Mcl1 protein levels and Caspase‐7 executioner protease control axial organizer cells survival
Sena, E., Bou‐Rouphael, J., Rocques, N., Carron, C., & Durand, B. (2020) · Developmental Dynamics · doi:10.1002/dvdy.169 · Cited by 5
Bcl-2 Family and Their Therapeutic Potential
Liu, Q., Chi, X., Leber, B. F., & Andrews, D. W. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9302-0_4 · Cited by 7
Function of myeloid cell leukaemia-1 and its regulative relations with hepatocellular carcinoma
Zhu, M., & Zhang, Y. (2017) · Hepatoma Research · doi:10.20517/2394-5079.2017.14 · Cited by 5
Wei, B., Xu, L., Hui, H., Sun, Y., & Wu, J. (2020) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.10.004 · Cited by 5
Proteasome Based Molecular Strategies Against Improper Cellular Proliferation
Dubey, A. R., Kinger, S., Jagtap, Y. A., Patwa, S. M., Kumar, P., Singh, S., Kumar, A., Kumar, A., & Mishra, A. (2021) · Cellular Physiology and Biochemistry · doi:10.33594/000000439 · Cited by 6
Immunologic Repercussions of Cell Death
Beere, H. M., & Green, D. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00028-0 · Cited by 6
Xiong, S., Liu, F., Sun, J., Gao, S., Wong, C. C. L., Tu, P., & Wang, Y. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.02.039 · Cited by 4
The Degradation of Botulinum Neurotoxin Light Chains Using PROTACs
Tsai, Y. C., Kozar, L., Mawi, Z. P., Ichtchenko, K., Shoemaker, C. B., McNutt, P. M., & Weissman, A. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137472 · Cited by 4
Tectorigenin attenuates cardiac hypertrophy via USP9X/MCL1-mediated mitochondrial stabilization
Chen, X., Zhou, G., Yuan, T., He, Z., Su, L., Guo, H., Liang, F., Cai, L., Li, S., & Yang, W. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103855 · Cited by 4
Sirera, J., Sarlak, S., Teisseire, M., Carminati, A., Savy, C., Nicolini, V. J., Brest, P., Juel, T., Bontoux, C., Deckert, M., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03241-2 · Cited by 8
Research Methods for Clinical Trials in Personalized Medicine: A Systematic Review
Ren, Z., Davidian, M., George, S. L., Goldberg, R. M., Wright, F. A., Tsiatis, A. A., & Kosorok, M. R. (2014) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814489072_0025 · Cited by 4
Proteomic tools for the characterization of cell death mechanisms in drug discovery
Anania, V. G., & Lill, J. R. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400151 · Cited by 5
Self-citationDeubiquitinating ALDH1A3 key to maintaining the culprit of aggressive brain cancer
Wakimoto, H. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128742 · Cited by 5
Targeting the Ubiquitin Proteasome System in Cancer
Kumari, N., Lee, K. K., & Jha, S. (2018) · InTech eBooks · doi:10.5772/intechopen.76705 · Cited by 6
USP9X, a Putative Tumor Suppressor Gene, Exhibits Frameshift Mutations in Colorectal Cancers
Jo, Y. S., Kim, M. S., Yoo, N. J., & Lee, S. H. (2016) · Pathology & Oncology Research · doi:10.1007/s12253-016-0140-z · Cited by 4
Saga of MCL1 inhibitors in multiple myeloma
Nelson, E., Telang, S. P., Budak-Alpdoǧan, T., Jonnalagadda, S. C., Srivastava, S. K., & Pandey, M. K. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117532 · Cited by 3
OTUD7B promotes cell migration and invasion, predicting poor prognosis of gastric cancer
Liu, X., Zhao, S., Zhang, M., Zhang, P.-Z., & Liu, X.-P. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155689 · Cited by 4
Chen, L., Jiang, X. L., Liu, X. P., Lee, Y. Z., Tham, C. L., Yusof, R., Gao, S., & Lee, M. T. (2025) · Medical Oncology · doi:10.1007/s12032-025-02696-3 · Cited by 3
Targeting Multidrug Resistance in Neuroblastoma
Fletcher, J. I., Haber, M., Henderson, M. J., & Norris, M. D. (2011) · Pediatric cancer · doi:10.1007/978-94-007-2418-1_11 · Cited by 3
The deubiquitinase USP9X regulates RIT1 protein abundance and oncogenic phenotypes
Riley, A. K., Grant, M., Snell, A. H., Cromwell, E. A., Vichas, A., Moorthi, S., Rominger, C., Modukuri, S. P., Urisman, A., Castel, P., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110499 · Cited by 4
Liu, W. C., Huo, Y., Yang, J., Fu, X., Yang, M., Tao, L., Liu, D., Zhang, J., Hua, R., & Sun, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.8452 · Cited by 4
Therapeutics targeting BCL2 family proteins
Dai, H., Meng, X. W., Ye, K., Jia, J., & Kaufmann, S. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814208-0.00007-5 · Cited by 3
The roles of ubiquitination‐mediated intrinsic apoptotic signalling in cancer therapy
Che, T., & Lin, Z. (2022) · Clinical and Translational Discovery · doi:10.1002/ctd2.41 · Cited by 5
Male sterility in Mcl-1-flox mice is not due to enhanced Mcl1 protein stability
Ah-Cann, C., Tailler, M., Kueh, A. J., Herold, M. J., Opferman, J. T., Asselin-Labat, M.-L., & Bouillet, P. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.391 · Cited by 3
Pakulska, U., Obacz, M., Woźnicki, J., Wiklik, K., Chakraborty, S., Micek, M., Mohanty, V., Coelho, D., Adamczyk, E., Gołas, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.16.693978 · Cited by 3
Gupta, J., Al-Khateeb, F. N., Zwenal, A., Alkhathami, A. G., Malathi, H., Kundlas, M., Maharana, L., Chauhan, A. S., Mustafa, Y. F., & Alnajar, M. J. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152410 · Cited by 3
Fine-Tuning Protein Fate: Mechanisms of E1, E2, and E3 Enzymes and Deubiquitinases in Cell Signaling
Kim, Y., Kim, E.-K., & Jang, H. H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083404 · Cited by 5
Hogh-Binder, S. A., Klein, D., Wolfsperger, F., Huber, S. M., Hennenlotter, J., Stenzl, A., & Rudner, J. (2023) · Cancers · doi:10.3390/cancers15092496 · Cited by 6
Sharma, S., Sarkar, O., & Ghosh, R. (2024) · Current Protein and Peptide Science · doi:10.2174/0113892037274615240528113148 · Cited by 3
Role of Apoptosis in Cancer: War of the Worlds, Therapeutic Targets and Strategies
Dhara, A., Kaur, R., Chattopadhyay, R., Das, S., Pal, S., & Sen, N. (2024) · Springer eBooks · doi:10.1007/978-981-97-7905-5_9 · Cited by 2
The Ubiquitin-Proteasomal System and Blood Cancer Therapy
Mao, X., & Cao, B. (2012) · InTech eBooks · doi:10.5772/35016 · Cited by 3
Adaptation to ER Stress as a Mechanism of Resistance of Melanoma to Treatment
Dong, X., Hersey, P., Hong, K., Tseng, H., Chen, C., & Dong, L. (2011) · InTech eBooks · doi:10.5772/19115 · Cited by 2
Substituted indole Mcl-1 inhibitors: a patent evaluation (WO2015148854A1)
Song, T., Wang, Z., & Zhang, Z. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1240786 · Cited by 2
Wang, S., Ekoue, D. N., Raj, G. V., & Kittler, R. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.010 · Cited by 2
Degradation of Proteins by Ubiquitin-Proteasome Pathway
Matějíková, J., Bešše, L., Sedlaříková, L., Potáčková, A., Hájek, R., & Ševčíková, S. (2013) · Klinicka onkologie · doi:10.14735/amko2013251 · Cited by 3
Bcl-xL inhibition - a novel strategy for glioma therapy
Karpel‐Massler, G., & Siegelin, M. D. (2016) · Aging · doi:10.18632/aging.101074 · Cited by 2
Phosphorylation of Bok at Ser-8 blocks its ability to suppress IP3R-mediated calcium mobilization
Bonzerato, C. G., Keller, K. R., & Wojcikiewicz, R. J. H. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-024-02008-8 · Cited by 2
Evolving role of deubiquitinating enzymes in oral cancer (Review)
Wang, Z., Cheng, S., Wei, J., Hu, J., Li, F., & Yang, W. (2025) · Oncology Letters · doi:10.3892/ol.2025.15100 · Cited by 1
The Potential Role of Deubiquitinating Enzymes (DUBs) in Male Fertility
Kim, J. M. (2026) · Biomolecules · doi:10.3390/biom16020299 · Cited by 1
Cellular synthesis of ubiquitin-based probes for compartment-specific deubiquitinase profiling
Chen, J., Zhang, X., Huang, Y., Li, G., & Tsai, Y. (2026) · Chinese Chemical Letters · doi:10.1016/j.cclet.2026.112701 · Cited by 2
Functional Relevance of Deubiquitinases in Life and Disease
Fraile, J. M., López-Otín, C., & Freije, J. M. P. (2017) · Springer eBooks · doi:10.1007/978-981-10-2513-6_16 · Cited by 1
Yang, J., Yao, Y., Fan, S., & Li, X. (2024) · Shock · doi:10.1097/shk.0000000000002442 · Cited by 2
Paul, S., Chatterjee, A., Das, K., Ray, A., Basu, A., Mukhopadhyay, S., & Sen, P. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108025 · Cited by 3
Novel Therapeutic Strategies for Pancreatic Cancer
Quinn, B. A. (2014) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/t39h-kj31 · Cited by 2
Zerumbone enhances TRAIL-induced apoptosis via USP9x-mediated downregulation of Mcl-1
Song, S. R., Woo, S. M., Seo, S. U., Jeong, Y. J., Chae, J., Hur, G. M., & Kwon, T. K. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152194 · Cited by 1
The role of Mcl-1 in the response of human colorectal cancer cells to treatment with dichloroacetate
Delaney, L. M. (2013) · The Atrium (University of Guelph) · Cited by 1
Modi, P. (2015) · Digital Commons-TMC (Texas Medical Center)
Qutob, H. M. H. (2014) · Nottingham ePrints (University of Nottingham)
Morishima, N., Nakanishi, K., & Nakano, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.n111.233502
Deubiquitinating Enzymes as Novel Targets for Cancer Therapies
Baek, K., Lim, K., & Park, J.-J. (2014) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-06752-0_15
Abstract IA5: Developing therapeutics in mice with ductal pancreatic cancer
Tuveson, D. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.mechres-ia5
A Get‐Together to Tear It Apart
McLelland, G., & Fon, E. A. (2015) · Wiley eBooks · doi:10.1002/9781119017127.ch12
Kapuria, V. (2010) · Digital Commons-TMC (Texas Medical Center)
Mechanisms of CXL017: targeting drug resistant cancer
Hermanson, L., & Lee, D. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
The Role of BCL-2 Family in Clinical Response of Chronic Lymphocytic Leukemia
Al-harbi, S. (2012) · OhioLink ETD Center (Ohio Library and Information Network)
Récher, C., Wei, A. H., Parker, M., Lopez, A. F., Ekert, P. G., Lock, R. B., Huang, D. C. S., Nilsson, S. K., Pomilio, G., Green, B. D., et al. (2013)
Self-citationRegulation of the Prickle1 and Prickle2 genes and their role in autism spectrum disorders
Paemka, L., Murray, J. C., Stipp, C. S., Slusarski, D. C., Bassuk, A. G., Cornell, R. A., & Comeron, J. (2014) · doi:10.17077/etd.vw8d78wt
The Role of MCL-1 in the Heart: Gateway from Life to Death
Wang, X. (2014) · doi:10.21007/etd.cghs.2014.0342 · Cited by 1
Notch Regulation in Breast Cancer
Izrailit, J. (2015) · TSpace (University of Toronto)
Une désubiquitinylase peut stabiliser une oncoprotéine
Bénard, J. (2010) · Bulletin du Cancer · doi:10.1684/bdc.2010.1075
USP9X controls DNA replication fork stability and the replication stress checkpoint through Claspin
McGarry, E. (2016) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/17576
Omari, S. (2014) · TSpace (University of Toronto)
Computational Modeling of Protein Structure, Function, and Binding Hotspots
Graham, S. E. (2017) · Deep Blue (University of Michigan)
The Role of BNIP3 in Proliferation and Hypoxia-Induced Autophagy: Implications for Cancer Therapy
Azad, M. B. (2010) · Mspace (University of Manitoba) · Cited by 1
Modification of Bcl-x and Mcl-1 pre-mRNA splicing using splice-switching oligonucleotides
Bauman, J. A. (2011) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/rjnh-m743
Role of Usp9X in the Regulation of Axon Specification and Growth
Tan, M. C. (2015) · Griffith Research Online · doi:10.25904/1912/379
Tumor-suppressive proteases revisited: Role in inhibiting tumor progression and metastasis
Shukla, D., Mandal, T., Saha, P., Kumar, D., Kumar, S., & Srivastava, A. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818168-3.00014-0 · Cited by 2
Proteasome Inhibitors against Cancer: Determining Biology and Finding Novel Compounds
Mofers, A. (2020) · Linköping University medical dissertations · doi:10.3384/diss.diva-167520 · Cited by 1
A matter of life or death: targeting MCL-1 in multiple myeloma
Slomp, A. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/323
Flow fluctuations and the local flowrule of granular suspensions
Wandersman, É., Dijksman, J. A., de Groot, W. A., & van Hecke, M. (2010) · Bulletin of the American Physical Society
Lindner, A. U., Concannon, C. G., Boukes, G. J., Cannon, M. D., Llambi, F., Ryan, D., Boland, K., Kehoe, J., McNamara, D. A., Murray, F., et al. (2023) · doi:10.1158/0008-5472.22399170
Sirera, J., Sarlak, S., Teisseire, M., Carminati, A., Savy, C., Nicolini, V. J., Brest, P., Juel, T., Bontoux, C., Deckert, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.23.590548
USP37 promotes diffuse large B-cell lymphoma progression by deubiquitinating and stabilizing c-myc
Li, Y., Wang, W., Sun, L., Huang, J., Ma, X., Li, S., & Shi, X. (2024) · Journal of Molecular Histology · doi:10.1007/s10735-024-10323-0
Deubiquitinases as novel therapeutic targets in colorectal cancer
Shukri, N. A., & Momin, R. B. A. (2025) · Asia-Pacific Journal of Oncology · doi:10.32948/ajo.2025.02.19
Pak, M. G., Ha, S. Y., & Roh, M. S. (2025) · International Journal of Surgical Pathology · doi:10.1177/10668969251358831
Zhou, Y., Siyi, W., Siyu, W., YuanYuan, T., & Li, J. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112314
Protein arginine methylation and ubiquitination: A prominent crosstalk and its functions in cancer
Zhou, J., Zhang, A., Zhu, J., Tang, F., Yuan, Z., Ma, W., Wang, Q., Lü, J., Li, S., & Li, Z. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101997 · Cited by 1
Li, C., Deng, C., Pan, G., Wang, X., Zhang, K., Dong, Z., Zhao, G., Tan, M., Hu, X., Shi, S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13173162
Li, C., Deng, C., Pan, G., Wang, X., Zhang, K., Dong, Z., Zhao, G., Tan, M., Hu, X., Shi, S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13173153
Li, C., Deng, C., Pan, G., Wang, X., Zhang, K., Dong, Z., Zhao, G., Tan, M., Hu, X., Shi, S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13173150
Li, C., Deng, C., Pan, G., Wang, X., Zhang, K., Dong, Z., Zhao, G., Tan, M., Hu, X., Shi, S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13173159
Li, C., Deng, C., Pan, G., Wang, X., Zhang, K., Dong, Z., Zhao, G., Tan, M., Hu, X., Shi, S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13173156
Chen, W., Ma, T., Zheng, X., Pan, R., Nan, T., Zheng, L., Lan, J., Xu, G., & Liu, H. (2025) · Research Square · doi:10.21203/rs.3.rs-8389931/v1
Spatiotemporal dynamics of Mcl-1 abundance and its influence on apoptosis susceptibilityPreprint
Klötzer, F., Pollak, N., Baatz, A., Kısakol, B., Ginty, F., Longley, D. B., Prehn, J. H. M., & Rehm, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.06.704006
Gossypol suppresses tumorigenesis through inhibition of multiple deubiquitinating enzymes
Gui, L., Chen, C., Gao, J., Zhu, M., Xu, Z., Zhou, H., Zhang, N., & Shi, L. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109763
Étude de la régulation de la protéine mitochondriale MAVS au cours de l’immunité innée antivirale
Castanier, C. (2011) · theses.fr (ABES) · doi:10.70675/1ad655f2z8bf1z4a47zba70z55e456a89d8a
Metadata
- Authors
- Schwickart, M., Huang, X., Lill, J. R., Liu, J., Ferrando, R., French, D. M., Maecker, H., O’Rourke, K., Bazan, F., Eastham-Anderson, J., Yue, P., Dornan, D., Huang, D. C. S., & Dixit, V. M.
- Affiliations
- Genentech (US)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Corresponding author
- Dixit, Vishva M.
- Venue
- Nature
- Published
- 2009-12-20
- Volume
- 463
- Issue
- 7277
- Pages
- 103-107
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991249033
- Cited by
- 628
- References
- 31
- Citations by year
- 2026: 18 · 2025: 21 · 2024: 20 · 2023: 21 · 2022: 20 · 2021: 38 · 2020: 41 · 2019: 44 · 2018: 45 · 2017: 45 · 2016: 51 · 2015: 49 · 2014: 50 · 2013: 46 · 2012: 44
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- USP9X, Mcl-1, deubiquitinase, protein stabilization, ubiquitination, multiple myeloma, Bcl-2 family proteins, apoptosis, ABT-737, BH3 mimetics, follicular lymphoma, diffuse large B-cell lymphoma, chemoresistance, therapeutic target, prognosis, proteasomal degradation, stem/progenitor cells, tumor cell survival
- MeSH terms
- Docetaxel, Animals, Biphenyl Compounds, Cell Line, Cell Survival, DNA Damage, Etoposide, Female, Half-Life, Humans, Lysine, Neoplasms, Nitrophenols, Phosphorylation, Piperazines, Prognosis, Protein Binding, Sulfonamides, Ultraviolet Rays, Gene Expression Regulation, Neoplastic, Mice, SCID, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Xenograft Model Antitumor Assays, Polyubiquitin, RNA Interference, Ubiquitin Thiolesterase, Taxoids, Cell Line, Tumor, Mice, Ubiquitination, Protein Stability, Gene Knockdown Techniques, Myeloid Cell Leukemia Sequence 1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.